• About us
• Contact

Advertisement

Organisation › Details

Cevec Pharmaceuticals GmbH

CEVEC is a center of expertise for the production of biopharmaceuticals using a unique human cell-based expression system. CAP®GT is a fully scalable manufacturing platform for viral vector production. CEVEC has successfully developed CAP®GT suspension cell-derived viral packaging cell lines, including a stable, helper virus-free AAV production platform, which enable better scale-up and competitive production costs when compared to adherent cell culture systems. CAP®GT suspension cell lines grow to high cell densities and show excellent productivity for a broad range of viruses. Gene therapy vectors such as lentiviral, adenoviral, and adeno-associated viral (AAV) vectors can be produced at industrial scale. CAP®Go enables the production of proteins “beyond antibodies”. Complex, glycosylated proteins represent a significant portion of the human proteome and are notoriously difficult to express in conventional cell lines such as CHO. The CAP®Go expression platform comprises a portfolio of glyco-optimized human suspension cell lines for the highly efficient production of a broad range of difficult to express recombinant proteins with authentic human post-translational modifications or on demand tailor-made glycosylation patterns. *

 

	Start	2001-01-01 established
	Group	Danaher (Group)
	Region	Köln (Cologne)
	Country	Germany
	Street	60-62 Gottfried-Hagen-Str.
	City	51105 Köln
		Address record changed: 2022-09-17
Basic data	Employees	B: 11 to 50 (2022-10-06)
		* Document for »About Section«: Cevec Pharmaceuticals GmbH. (4/16/19). "Press Release: Cevec Closes Major Financing Round to Further Expand and Commercialize Its Viral Vector Manufacturing Platform". Cologne.
		Record changed: 2025-03-16

Advertisement

More documents for Danaher (Group)

• [1] Cepheid. (4/9/25). "Press Release: Cepheid and Oxford Nanopore Technologies Partner to Advance Automated Sequencing-based Solutions". Oxford & Sunnyvale, CA....
• [2] Ion Opticks Pty Ltd.. (10/25/24). "Press Release: Sciex and IonOpticks Announce Co-Marketing Agreement Between Aurora Series XS Range and the ZenoTOF Line". Melbourne....
• [3] SphingoTec GmbH. (10/9/24). "Press Release: Beckman Coulter and SphingoTec Partner to Improve Kidney Health Assessment in Critical Care". Hennigsdorf....
• [4] CrestOptics S.p.A.. (10/7/24). "Press Release: CrestOptics and Leica Microsystems Announce Strategic Collaboration to Expand Capabilities of Spinning Disk Microscopy". Rome....
• [5] Genedata AG. (9/5/24). "Press Release: Immunocore Selects Genedata to Scale Up Discovery of Novel TCR Therapeutics". Basel....
• [6] Genedata AG. (8/19/24). "Press Release: Genedata Joins Danaher Corporation". Basel....
• [7] 10x Genomics, Inc.. (8/8/24). "Press Release: 10x Genomics Announces Senior Leadership Changes". Pleasanton, CA....
• [8] Danaher Corporation. (10/31/23). "Press Release: Danaher Appoints Christopher Riley to Executive Vice President for Biotechnology". Washington D.C.....
• [9] Danaher Corporation. (8/28/23). "Press Release: Danaher to Acquire Abcam". Washington, DC....
• [10] Abcam plc. (6/23/23). "Press Release: Abcam Announces Review of Strategic Alternatives". Cambridge & Waltham, MA....

To subscribe to our free, monthly mass spectrometry newsletter, please send an e-mail to info@iito.de and simply fill the subject line with the word »MSC Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Please visit also our web portals for the Eurpean life sciences and the life sciences in German-speaking Europe (DE, AT & CH) at Life-Sciences-Germany.com and Life-Sciences-Europe.com

Advertisement

» top

» Imprint  |  » Data Privacy  |  » Contact  |  The use of this website requires to accept the » Disclaimer!   |  A project of [iito] Business Intelligence © 2002-2025. Made in Germany.